MRI‐Based Radiomics Signature: A Potential Biomarker for Identifying Glypican 3‐Positive Hepatocellular Carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MRI‐Based Radiomics Signature: A Potential Biomarker for Identifying Glypican 3‐Positive Hepatocellular Carcinoma
Authors
Keywords
-
Journal
JOURNAL OF MAGNETIC RESONANCE IMAGING
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-06-03
DOI
10.1002/jmri.27199
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Value of texture analysis based on enhanced MRI for predicting an early therapeutic response to transcatheter arterial chemoembolisation combined with high-intensity focused ultrasound treatment in hepatocellular carcinoma
- (2018) J.Y. Yu et al. CLINICAL RADIOLOGY
- A Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma
- (2018) Li Yang et al. Liver Cancer
- Radiomics: the bridge between medical imaging and personalized medicine
- (2017) Philippe Lambin et al. Nature Reviews Clinical Oncology
- Malignancy characterization of hepatocellular carcinomas based on texture analysis of contrast-enhanced MR images
- (2016) Wu Zhou et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Radiomics: Images Are More than Pictures, They Are Data
- (2016) Robert J. Gillies et al. RADIOLOGY
- Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
- (2016) Yukihiro Haruyama WORLD JOURNAL OF GASTROENTEROLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma
- (2013) Min Chen et al. CLINICA CHIMICA ACTA
- The glypican 3 hepatocellular carcinoma marker regulates human hepatic stellate cells via Hedgehog signaling
- (2013) Paolo Magistri et al. JOURNAL OF SURGICAL RESEARCH
- Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection
- (2013) Shun-Jun Fu et al. SURGERY
- Assessment of tumor heterogeneity by CT texture analysis: Can the largest cross-sectional area be used as an alternative to whole tumor analysis?
- (2012) Francesca Ng et al. EUROPEAN JOURNAL OF RADIOLOGY
- Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patients
- (2011) Su Ning et al. MOLECULAR BIOLOGY REPORTS
- Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma
- (2010) Eisuke Yasuda et al. HEPATOLOGY RESEARCH
- Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma
- (2010) Hui Liu WORLD JOURNAL OF GASTROENTEROLOGY
- Prediction of Malignant Breast Lesions from MRI Features
- (2009) Christine E. McLaren et al. ACADEMIC RADIOLOGY
- Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients
- (2009) Paolo Sorrentino et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Expression of Glypican 3 in Ovarian and Extragonadal Germ Cell Tumors
- (2008) Debra L. Zynger et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Molecular background of α-fetoprotein in liver cancer cells as revealed by global RNA expression analysis
- (2008) Shigeru Saito et al. CANCER SCIENCE
- Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma
- (2008) Jin-Ping Lai et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now